Detail of the clinical trial

Title of the trial Phase II randomised, double blind, multicentre study to assess the efficacy of AZD2281 in the treatment of patients with platinum sensitive serous ovarian cancer following treatment wuth two or more platinum containing regimens
EudraCT number 2008-003439-18
Protocol number D0810C00019
Sponsor AstraZeneca AB, Sodertalje, Sweden
Indications Oncology
Diagnosis serous ovarian cancer
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Female
Patients
Year of receiving the request to Institute (SÚKL) 2009
Date of approval by Institute (SÚKL) 7.4.2009
Date of approval by EC 1.4.2009
Date of initiation CT in ČR 30.10.2009
Date of ending CT in ČR 14.7.2010
Notice
Sites Onkogynekologická ambulance, Masarykův onkologický ústav, Žlutý kopec, Beno
Gynekologicko-porodnická klinika, FN Brno
Onkologická klinika, FN Olomouc
Radiologická a onkologická klinika, FN Královské Vinohrady, Praha 10

‹‹ Back to list